Perdagangan Exicure, Inc. - XCUR CFD
Tambah ke favorit- Summary
- Historical Data
- Events
- Income Statement
- Balance Sheet
- Cash Flow
- Ownership
Trading Conditions
Spread | 0.08 | ||||||||
Biaya inap posisi Long
Long position overnight fee
Kunjungi platform | -0.024068% | ||||||||
Biaya inap posisi short
Short position overnight fee
Kunjungi platform | 0.001846% | ||||||||
Waktu biaya inap | 21:00 (UTC) | ||||||||
Kuantitas min. yang diperdagangkan | 1 | ||||||||
Mata uang | USD | ||||||||
Margin | 20% | ||||||||
Bursa efek | United States of America | ||||||||
Komisi perdagangan | 0% |
*Information provided by Capital.com
Key Stats
Prev. Close* | 0.89 |
Open* | 0.88 |
1-Year Change* | 363.16% |
Day's Range* | 0.86 - 0.89 |
52 wk Range | 0.63-9.36 |
Average Volume (10 days) | 15.72K |
Average Volume (3 months) | 889.76K |
Market Cap | 4.72M |
P/E Ratio | -100.00K |
Shares Outstanding | 4.96M |
Revenue | 9.17M |
EPS | -9.35 |
Dividend (Yield %) | N/A |
Beta | 1.01 |
Next Earnings Date | May 15, 2023 |
All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
Date | Close | Change | Change (%) | Open | High | Low |
---|---|---|---|---|---|---|
Mar 27, 2023 | 0.88 | 0.00 | 0.00% | 0.88 | 0.89 | 0.84 |
Mar 24, 2023 | 0.89 | -0.07 | -7.29% | 0.96 | 0.96 | 0.89 |
Mar 23, 2023 | 0.93 | -0.01 | -1.06% | 0.94 | 0.94 | 0.91 |
Mar 22, 2023 | 0.93 | 0.01 | 1.09% | 0.92 | 0.94 | 0.87 |
Mar 21, 2023 | 0.94 | 0.01 | 1.08% | 0.93 | 0.96 | 0.93 |
Mar 20, 2023 | 0.94 | -0.01 | -1.05% | 0.95 | 0.97 | 0.94 |
Mar 17, 2023 | 0.98 | -0.05 | -4.85% | 1.03 | 1.03 | 0.96 |
Mar 16, 2023 | 0.95 | -0.07 | -6.86% | 1.02 | 1.02 | 0.95 |
Mar 15, 2023 | 1.02 | -0.01 | -0.97% | 1.03 | 1.03 | 1.00 |
Mar 14, 2023 | 1.04 | 0.03 | 2.97% | 1.01 | 1.06 | 0.99 |
Mar 13, 2023 | 1.04 | 0.01 | 0.97% | 1.03 | 1.04 | 0.99 |
Mar 10, 2023 | 1.03 | -0.08 | -7.21% | 1.11 | 1.11 | 0.99 |
Mar 9, 2023 | 1.12 | -0.04 | -3.45% | 1.16 | 1.16 | 1.10 |
Mar 8, 2023 | 1.09 | -0.04 | -3.54% | 1.13 | 1.13 | 1.08 |
Mar 7, 2023 | 1.12 | -0.01 | -0.88% | 1.13 | 1.15 | 1.12 |
Mar 6, 2023 | 1.14 | 0.00 | 0.00% | 1.14 | 1.15 | 1.12 |
Mar 3, 2023 | 1.13 | 0.06 | 5.61% | 1.07 | 1.14 | 1.07 |
Mar 2, 2023 | 1.09 | 0.00 | 0.00% | 1.09 | 1.13 | 1.07 |
Mar 1, 2023 | 1.11 | 0.02 | 1.83% | 1.09 | 1.11 | 1.07 |
Feb 28, 2023 | 1.13 | -0.04 | -3.42% | 1.17 | 1.20 | 1.08 |
Exicure, Inc. Events
Time (UTC) | Country | Event |
---|---|---|
No events scheduled |
- Annual
- Quarterly
2021 | 2020 | 2019 | 2018 | 2017 | |
---|---|---|---|---|---|
Total revenue | -0.483 | 16.613 | 1.296 | 0.118 | 9.719 |
Revenue | -0.483 | 16.613 | 1.296 | 0.118 | 9.719 |
Total Operating Expense | 62.066 | 42.049 | 27.913 | 21.937 | 21.154 |
Selling/General/Admin. Expenses, Total | 13.087 | 9.955 | 8.573 | 7.818 | 7.046 |
Research & Development | 48.979 | 32.094 | 19.34 | 14.119 | 14.108 |
Operating Income | -62.549 | -25.436 | -26.617 | -21.819 | -11.435 |
Interest Income (Expense), Net Non-Operating | -1.542 | 0.446 | -0.065 | -0.672 | -0.795 |
Other, Net | -0.011 | 0.322 | 0.379 | 0.078 | 0.191 |
Net Income Before Taxes | -64.102 | -24.668 | -26.303 | -22.413 | -12.039 |
Net Income After Taxes | -64.102 | -24.668 | -26.303 | -22.413 | -12.039 |
Net Income Before Extra. Items | -64.102 | -24.668 | -26.303 | -22.413 | -12.039 |
Net Income | -64.102 | -24.668 | -26.303 | -22.413 | -12.039 |
Income Available to Common Excl. Extra. Items | -64.102 | -24.668 | -26.303 | -22.413 | -12.039 |
Income Available to Common Incl. Extra. Items | -64.102 | -24.668 | -26.303 | -22.413 | -12.039 |
Diluted Net Income | -64.102 | -24.668 | -26.303 | -22.413 | -12.039 |
Diluted Weighted Average Shares | 2.95362 | 2.9065 | 1.9222 | 1.37284 | 1.3099 |
Diluted EPS Excluding Extraordinary Items | -21.7029 | -8.4872 | -13.6838 | -16.3261 | -9.1908 |
Diluted Normalized EPS | -21.7029 | -8.4872 | -13.6838 | -16.3261 | -9.1908 |
Total Extraordinary Items | 0 | 0 |
Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 | Sep 2021 | |
---|---|---|---|---|---|
Total revenue | 2.016 | 2.471 | 2.565 | 2.118 | -3.677 |
Revenue | 2.016 | 2.471 | 2.565 | 2.118 | -3.677 |
Total Operating Expense | 7.221 | 9.954 | 10.302 | 15.567 | 19.404 |
Selling/General/Admin. Expenses, Total | 2.416 | 3.205 | 3.162 | 4.15 | 2.947 |
Research & Development | 4.805 | 6.749 | 7.14 | 11.417 | 16.457 |
Operating Income | -5.205 | -7.483 | -7.737 | -13.449 | -23.081 |
Interest Income (Expense), Net Non-Operating | 0.045 | 0.017 | -0.591 | -0.372 | -0.445 |
Other, Net | 0 | -0.004 | -0.02 | -0.004 | -0.005 |
Net Income Before Taxes | -5.16 | -7.47 | -8.348 | -13.825 | -23.531 |
Net Income After Taxes | -5.16 | -7.47 | -8.348 | -13.825 | -23.531 |
Net Income Before Extra. Items | -5.16 | -7.47 | -8.348 | -13.825 | -23.531 |
Net Income | -5.16 | -7.47 | -8.348 | -13.825 | -23.531 |
Income Available to Common Excl. Extra. Items | -5.16 | -7.47 | -8.348 | -13.825 | -23.531 |
Income Available to Common Incl. Extra. Items | -5.16 | -7.47 | -8.348 | -13.825 | -23.531 |
Diluted Net Income | -5.16 | -7.47 | -8.348 | -13.825 | -23.531 |
Diluted Weighted Average Shares | 4.96334 | 4.50398 | 4.03093 | 3.01522 | 2.93654 |
Diluted EPS Excluding Extraordinary Items | -1.03962 | -1.65853 | -2.07099 | -4.58507 | -8.01317 |
Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | 0 | |
Diluted Normalized EPS | -1.03962 | -1.65853 | -2.07099 | -4.58507 | -8.01317 |
- Annual
- Quarterly
2021 | 2020 | 2019 | 2018 | 2017 | |
---|---|---|---|---|---|
Total Current Assets | 43.666 | 86.322 | 112.776 | 27.663 | 27.638 |
Cash and Short Term Investments | 39.141 | 82.08 | 110.786 | 26.268 | 25.764 |
Cash & Equivalents | 34.644 | 33.262 | 48.46 | 26.268 | 25.764 |
Total Receivables, Net | 0 | 0.011 | 0.271 | 0.013 | 0.03 |
Accounts Receivable - Trade, Net | 0 | 0.011 | 0.035 | 0.003 | 0.013 |
Prepaid Expenses | 3.247 | 4.231 | 1.014 | 1.382 | 1.844 |
Total Assets | 64.868 | 100.444 | 115.263 | 28.756 | 28.987 |
Property/Plant/Equipment, Total - Net | 11.877 | 12.729 | 2.455 | 1.061 | 1.317 |
Property/Plant/Equipment, Total - Gross | 14.544 | 14.469 | 3.772 | 2.25 | 2.166 |
Accumulated Depreciation, Total | -2.667 | -1.74 | -1.317 | -1.189 | -0.849 |
Other Long Term Assets, Total | 9.325 | 1.393 | 0.032 | 0.032 | 0.032 |
Total Current Liabilities | 34.067 | 13.734 | 31.087 | 2.043 | 3.356 |
Accounts Payable | 3.413 | 1.866 | 1.814 | 0.5 | 1.049 |
Accrued Expenses | 6.464 | 3.525 | 2.435 | 1.543 | 1.273 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
Current Port. of LT Debt/Capital Leases | 6.873 | 0 | 4.965 | 0 | |
Other Current Liabilities, Total | 17.317 | 8.343 | 21.873 | 0 | 1.034 |
Total Liabilities | 53.636 | 38.938 | 34.516 | 7.804 | 9.012 |
Total Long Term Debt | 0 | 16.589 | 0 | 4.925 | 4.855 |
Long Term Debt | 0 | 16.589 | 0 | 4.925 | 4.855 |
Other Liabilities, Total | 19.569 | 8.615 | 3.429 | 0.836 | 0.801 |
Total Equity | 11.232 | 61.506 | 80.747 | 20.952 | 19.975 |
Preferred Stock - Non Redeemable, Net | 0 | 0 | |||
Common Stock | 0.011 | 0.009 | 0.009 | 0.004 | 0.004 |
Additional Paid-In Capital | 181.29 | 167.379 | 162.062 | 75.942 | 53.586 |
Retained Earnings (Accumulated Deficit) | -170.067 | -105.965 | -81.297 | -54.994 | -33.615 |
Total Liabilities & Shareholders’ Equity | 64.868 | 100.444 | 115.263 | 28.756 | 28.987 |
Total Common Shares Outstanding | 3.62574 | 2.92142 | 2.86869 | 1.47845 | 1.3099 |
Short Term Investments | 4.497 | 48.818 | 62.326 | ||
Other Current Assets, Total | 1.278 | 0.705 | |||
Other Equity, Total | -0.002 | 0.083 | -0.027 |
Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | |
---|---|---|---|---|---|
Total Current Assets | 29.182 | 43.666 | 64.147 | 60.647 | 73.987 |
Cash and Short Term Investments | 26.384 | 39.141 | 60.838 | 56.059 | 67.436 |
Cash & Equivalents | 23.89 | 34.644 | 51.885 | 42.587 | 34.296 |
Short Term Investments | 2.494 | 4.497 | 8.953 | 13.472 | 33.14 |
Total Receivables, Net | 0 | 0.027 | 0.044 | 0.224 | |
Accounts Receivable - Trade, Net | 0 | 0 | 0 | 0 | |
Prepaid Expenses | 1.669 | 3.247 | 2.173 | 3.642 | 5.02 |
Other Current Assets, Total | 1.129 | 1.278 | 1.109 | 0.902 | 1.307 |
Total Assets | 41.896 | 64.868 | 77.9 | 74.467 | 87.948 |
Property/Plant/Equipment, Total - Net | 11.393 | 11.877 | 12.288 | 12.383 | 12.535 |
Property/Plant/Equipment, Total - Gross | 14.359 | 14.544 | 14.661 | 14.473 | 14.346 |
Accumulated Depreciation, Total | -2.966 | -2.667 | -2.373 | -2.09 | -1.811 |
Other Long Term Assets, Total | 1.321 | 9.325 | 1.465 | 1.437 | 1.426 |
Total Current Liabilities | 21.361 | 34.067 | 21.98 | 12.745 | 12.763 |
Accounts Payable | 1.918 | 3.413 | 2.485 | 2.25 | 2.976 |
Accrued Expenses | 3.227 | 6.464 | 5.48 | 3.228 | 2.441 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities, Total | 16.216 | 17.317 | 14.015 | 7.267 | 7.346 |
Total Liabilities | 38.66 | 53.636 | 63.917 | 37.827 | 37.907 |
Total Long Term Debt | 0 | 0 | 16.801 | 16.73 | 16.659 |
Long Term Debt | 0 | 16.801 | 16.73 | 16.659 | |
Other Liabilities, Total | 17.299 | 19.569 | 25.136 | 8.352 | 8.485 |
Total Equity | 3.236 | 11.232 | 13.983 | 36.64 | 50.041 |
Preferred Stock - Non Redeemable, Net | 0 | 0 | 0 | 0 | 0 |
Common Stock | 0.012 | 0.011 | 0.009 | 0.009 | 0.009 |
Additional Paid-In Capital | 181.644 | 181.29 | 170.217 | 169.337 | 168.442 |
Retained Earnings (Accumulated Deficit) | -178.415 | -170.067 | -156.242 | -132.711 | -118.442 |
Other Equity, Total | -0.005 | -0.002 | -0.001 | 0.005 | 0.032 |
Total Liabilities & Shareholders’ Equity | 41.896 | 64.868 | 77.9 | 74.467 | 87.948 |
Total Common Shares Outstanding | 4.0931 | 3.62574 | 2.93666 | 2.93626 | 2.93283 |
Current Port. of LT Debt/Capital Leases | 0 | 6.873 |
- Annual
- Quarterly
2021 | 2020 | 2019 | 2018 | 2017 | |
---|---|---|---|---|---|
Net income/Starting Line | -64.102 | -24.668 | -26.303 | -22.413 | -12.039 |
Cash From Operating Activities | -34.819 | -39.27 | 1.317 | -19.487 | -19.789 |
Cash From Operating Activities | 1.123 | 0.766 | 0.392 | 0.358 | 0.232 |
Non-Cash Items | 4.048 | 2.896 | 1.981 | 2.179 | 1.437 |
Changes in Working Capital | 24.112 | -18.264 | 25.247 | 0.389 | -9.419 |
Cash From Investing Activities | 43.085 | 10.142 | -63.432 | -0.094 | -0.926 |
Capital Expenditures | -0.968 | -3.171 | -1.082 | -0.094 | -0.926 |
Cash From Financing Activities | 1.116 | 15.13 | 84.307 | 20.085 | 26.856 |
Financing Cash Flow Items | -1.125 | -0.711 | -6.518 | -1.957 | -3.699 |
Issuance (Retirement) of Stock, Net | 12.241 | 3.34 | 90.825 | 22.042 | 31.556 |
Issuance (Retirement) of Debt, Net | -10 | 12.501 | 0 | -1.001 | |
Net Change in Cash | 9.382 | -13.998 | 22.192 | 0.504 | 6.141 |
Other Investing Cash Flow Items, Total | 44.053 | 13.313 | -62.35 |
Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | |
---|---|---|---|---|---|
Net income/Starting Line | -8.348 | -64.102 | -50.277 | -26.746 | -12.477 |
Cash From Operating Activities | -12.756 | -34.819 | -21.022 | -25.885 | -14.809 |
Cash From Operating Activities | 0.302 | 1.123 | 0.829 | 0.546 | 0.263 |
Non-Cash Items | 1.006 | 4.048 | 3.04 | 1.578 | 0.693 |
Changes in Working Capital | -5.716 | 24.112 | 25.386 | -1.263 | -3.288 |
Cash From Investing Activities | 1.995 | 43.085 | 38.977 | 34.533 | 15.297 |
Capital Expenditures | -0.006 | -0.968 | -0.623 | -0.564 | -0.225 |
Other Investing Cash Flow Items, Total | 2.001 | 44.053 | 39.6 | 35.097 | 15.522 |
Cash From Financing Activities | -7.993 | 1.116 | 0.668 | 0.677 | 0.546 |
Financing Cash Flow Items | -0.507 | -1.125 | -0.009 | 0 | 0 |
Issuance (Retirement) of Stock, Net | 0.014 | 12.241 | 0.677 | 0.677 | 0.546 |
Issuance (Retirement) of Debt, Net | -7.5 | -10 | 0 | 0 | 0 |
Net Change in Cash | -18.754 | 9.382 | 18.623 | 9.325 | 1.034 |
Mengapa memilih Capital.com? Biarlah angka kami yang berbicara.
Capital.com Group500K+
Trader
92K+
Klien aktif per bulan
$53M+
Volume investasi per bulan
$30M+
Penarikan tiap bulan
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
Trade commission
0
- 1:1
Leverage
1:1
- 20
- 100
- 500
- 1000
- 10000
Investment
Trade size (Leverage x Investement):
Open
Close
Short Long
Industry: | Bio Therapeutic Drugs |
2430 N. Halsted St.
CHICAGO
ILLINOIS 60614
US
Income Statement
- Annual
- Quarterly
People also watch
Masih mencari broker yang bisa Anda percayai?
Bergabung dengan 500.000+ trader di seluruh dunia yang telah memilih trading bersama Capital.com